A comparison of diverticulitis in Crohn's disease versus ulcerative colitis

被引:2
|
作者
Persaud, Alana [1 ]
Ahmed, Ahmed [1 ]
Kakked, Gaurav [3 ]
Shulik, Oleg [2 ]
Ahlawat, Sushil [2 ]
机构
[1] Rutgers New Jersey Med Sch, Div Med, Newark, NJ USA
[2] Rutgers New Jersey Med Sch, Div Gastroenterol & Hepatol, Newark, NJ USA
[3] Mt Sinai West St Lukes Roosevelt, Div Med, New York, NY USA
来源
JGH OPEN | 2019年 / 3卷 / 06期
关键词
Crohn's disease; diverticulitis; inflammatory bowel disease; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; COLONIC DIVERTICULOSIS; NATURAL-HISTORY; PATTERNS; PREVALENCE; COST;
D O I
10.1002/jgh3.12192
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim Inflammatory bowel disease (IBD) and diverticulitis both increase morbidity, especially when associated with in-patient hospitalization. This study aimed to evaluate whether hospitalization burden differs for diverticulitis in patients with a history of Crohn's disease (CD) compared to ulcerative colitis (UC). Method All patients hospitalized for acute diverticulitis with pre-existing UC or CD in 2014 were selected using the national in-patient sample. Cases were identified using the International Classification of Diseases, Ninth Edition codes. Primary outcomes were mortality, cost of admission, length of stay (LOS), and colectomy. Results A total of 1815 patients were admitted with diverticulitis, and those with CD had a hospitalization associated with decreased cost (aOR -14 537, 95% CI -27 316 to -1758; P = 0.026) and LOS (aOR -1.31, 95% CI -2.41 to -0.208; P = 0.02) compared to UC. A second analysis comparing diverticulitis hospitalization between those with CD and those with the absence of IBD showed no significant difference in mortality (aOR 2.47, 95% CI 0.59 to 10.36; P = 0.22), LOS (aOR 0.03, 95% CI -0.47 to 0.54; P = 0.92), or cost of admission (aOR -2196, 95% CI -6933 to 2539; P = 0.36) between the cohorts. Conclusion Patients with UC have worsened hospitalization outcomes when being treated for diverticulitis compared to CD. While the findings may be a result of a difference in colectomy rates, the etiology may also be multifactorial. These conclusions have not been previously described, and further investigations would better characterize these associations.
引用
收藏
页码:508 / 512
页数:5
相关论文
共 50 条
  • [41] Biological therapy in Crohn's disease and ulcerative colitis
    Dolz, C.
    MEDICINA BALEAR, 2008, 23 (03): : 19 - 23
  • [42] Crohn's disease and ulcerative colitis: Antibodies and men
    Duclos, B
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1995, 19 (11): : 865 - 866
  • [43] The Genetics Universe of Crohn's Disease and Ulcerative Colitis
    Parkes, Miles
    DIGESTIVE DISEASES, 2012, 30 : 78 - 81
  • [44] Prevalence of ulcerative colitis and Crohn's disease in Japan
    Asakura, Keiko
    Nishiwaki, Yuji
    Inoue, Nagamu
    Hibi, Toshifumi
    Watanabe, Mamoru
    Takebayashi, Toru
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) : 659 - 665
  • [45] Vedolizumab for the treatment of ulcerative colitis and Crohn's disease
    McLean, Leon P.
    Shea-Donohue, Terez
    Cross, Raymond K.
    IMMUNOTHERAPY, 2012, 4 (09) : 883 - 898
  • [46] Immunosuppression therapy in ulcerative colitis and Crohn's disease
    Present, DH
    ADVANCES IN INFLAMMATORY BOWEL DISEASES, 1999, 106 : 218 - 226
  • [47] Probiotics in the Management of Crohn's disease and Ulcerative Colitis
    Muellner, Katalin
    Miheller, Pal
    Herszenyi, Laszlo
    Tulassay, Zsolt
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (28) : 4556 - 4560
  • [48] CT features of ulcerative colitis and Crohn's disease
    Gore, RM
    Balthazar, EJ
    Ghahremani, GG
    Miller, FH
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1996, 167 (01) : 3 - 15
  • [49] Crohn's disease and ulcerative colitis, major similarities
    Dalibon, Pierre
    ACTUALITES PHARMACEUTIQUES, 2015, 54 (545): : 20 - 24
  • [50] Postoperative management of ulcerative colitis and Crohn's disease
    Keswani R.N.
    Cohen R.D.
    Current Gastroenterology Reports, 2005, 7 (6) : 492 - 499